http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019014700-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61866e714198ee02a24037c9670828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_592c0620383ef00ccb6e4eb9f2a246a8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16d145c7dff069ae4631ee66f1913e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9101bd0a64f866dd9e8cd5aaeafe4229
publicationDate 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019014700-A
titleOfInvention Ezetimibe-containing orally disintegrating tablet and method for producing the same
abstract An object of the present invention is to provide an ezetimibe-containing orally disintegrating tablet having excellent dissolution properties and orally disintegrating properties, and a method for producing the same. Ezetimibe particles having a d90 of 8.0 μm or less, 50.0% by weight or more of sugar alcohol and 0.0 to 0.1% by weight of sodium lauryl sulfate with respect to the total weight of the tablet, and An orally disintegrating tablet having a weight ratio of sugar alcohol to ezetimibe (sugar alcohol / ezetimibe) of 6.0 or more is provided. [Selection figure] None
priorityDate 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018172359-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017203013-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007003365-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017500303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019526591-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421153761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384

Total number of triples: 46.